A PROSPECTIVE OPEN-LABEL TRIAL OF LONG-ACTING LIQUID METHYLPHENIDATE FOR THE TREATMENT OF ADHD IN INTELLECTUALLY CAPABLE ADULTS WITH ASD

被引：0

作者：

Joshi, Gagan ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2019年 / 58卷 / 10期

关键词：

D O I：

10.1016/j.jaac.2019.07.780

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

21.3

引用

页码：S331 / S331

页数：1

共 50 条

[1] A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder
Joshi, Gagan
DiSalvo, Maura
Wozniak, Janet
Ceranoglu, T. Atilla
Yule, Amy
Surman, Craig
Fried, Ronna
Galdo, Maribel
Hoskova, Barbora
Belser, Abigail
Biederman, Joseph
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2020, 21 (04): : 274 - 290
[2] A Prospective Open-label Trial of Long-Acting Liquid Methylphenidate for the Treatment of Attention Deficit/Hyperactivity Disorder in Intellectually Capable Adults with Autism Spectrum Disorder
Joshi, Gagan
DiSalvo, Maura
Ceranoglu, T. Atilla
Wozniak, Janet
Galdo, Maribel
Hoskova, Barbora
Dallenbach, Nina
Castle, Rose
Biederman, Joseph
NEUROLOGY, 2019, 92 (15)
[3] Open-label extension trial of the safety and tolerability of OROSO methylphenidate in adults with ADHD - the long-acting methylphenidate in adult ADHD (lamda) trial
Kooij, S.
Medori, R.
Buitelaar, J.
Ramos-Quiroga, J. A.
Lee, E.
Casas, M.
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCIII - XCIII
[4] An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD
Ni, Hsing-Chang
Lin, Yu-Ju
Gau, Susan Shur-Fen
Huang, Hui-Chun
Yang, Li-Kuang
JOURNAL OF ATTENTION DISORDERS, 2017, 21 (01) : 27 - 39
[5] Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial
Kratochvil, CJ
Heiligenstein, JH
Dittmann, R
Spencer, TJ
Biederman, J
Wernicke, J
Newcorn, JH
Casat, C
Milton, D
Michelson, D
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (07): : 776 - 784
[6] A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder
Joshi, Gagan
Wozniak, Janet
Faraone, Stephen V.
Fried, Ronna
Chan, James
Furtak, Stephannie
Grimsley, Emily
Conroy, Kristina
Kilcullen, J. Ryan
Woodworth, K. Yvonne
Biederman, Joseph
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (03) : 262 - 271
[7] Efficacy and safety of OROSO methylphenidate in adults with ADHD the long-acting methylphenidate in adult ADHD (lamda) trial
Medori, R.
Kooij, S.
Ramos-Quiroga, J. A.
Buitelaar, J.
Lee, E.
Casas, M.
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCII - XCIII
[8] Open-label (OL) extension trial of the safety and tolerability of OROS® methylpheniclate in adults with ADHD -: the long-acting methylpheniclate in adult ADHD (LAMDA) trial
Philipsen, A.
Trott, G. E.
Roesler, M.
Gerwe, M.
Lee, E.
Medori, R.
Schauble, B.
PHARMACOPSYCHIATRY, 2007, 40 (05) : 247 - 248
[9] A Multicenter, Open-Label Trial to Evaluate the Quality of Life in Adults With ADHD Treated With Long-Acting Methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) Study
Mattos, Paulo
Louza, Mario Rodrigues
Fernandes Palmini, Andre Luis
de Oliveira, Irismar Reis
Rocha, Fabio Lopes
JOURNAL OF ATTENTION DISORDERS, 2013, 17 (05) : 444 - 448
[10] An open-label trial of OROS methylphenidate,in adults with late-onset ADHD
Biederman, Joseph
Mick, Eric
Spencer, Thomas
Surman, Craig
Hammerness, Paul
Doyle, Robert
Dougherty, Megan
Aleardi, Megan
Schweitzer, Karl
CNS SPECTRUMS, 2006, 11 (05) : 390 - 396

← 1 2 3 4 5 →